Novartis makes case for NASH candidate tropifexor
11 Nov 2019 //
PMLIVE
Novartis, Pfizer join forces on potentially lucrative fatty liver disease
30 Oct 2018 //
REUTERS
Pfizer Announces Clinical Development Agreement with Novartis to Advance NASH
29 Oct 2018 //
BUSINESSWIRE